Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Gene Therapy Progress and Prospects: Alpha-1 antitrypsin

Abstract

Over the 2 years covered here, there has been one clinical study in which a normal alpha-1 antitrypsin (AAT) gene was delivered to the nasal epithelium of AAT-deficient subjects using plasmid–liposome complexes; a second study using an adeno-associated vector should begin soon. Although progress in clinical studies has been slow, advances in both viral and nonviral vector designs show considerable promise. Strategies that combine liposome technology with imaginative vector design may permit long-term expression of a normal transgene that is sufficient to achieve therapeutic serum AAT concentrations. While reproducing the normal physiology by targeting normal AAT gene expression to the liver is logical, local expression in lung cells may be less demanding of the technology and offers therapeutic benefits that are produced neither by AAT protein therapy nor by AAT gene therapy targeted to the liver. Developing technologies may permit direct correction of the mutant AAT gene using innovative approaches to in vivo gene repair.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Flotte TR . Recombinant adeno-associated virus gene therapy for cystic fibrosis and [alpha]1-antitrypsin deficiency. Chest 2002; 121: 98S–102S.

    Article  CAS  Google Scholar 

  2. http://www.alphaone.org/research/clinical_trials/Gene_Therapy_Trials.htm. 2002.

  3. Brigham KL et al. Transfection of nasal mucosa with a normal alpha-1 antitrypsin (AAT) gene in AAT deficient subjects: comparison with protein therapy. Human Gene Therapy 2000; 11: 1023–1032.

    Article  CAS  Google Scholar 

  4. Albelda SM, Wiewrodt R, Zuckerman JB . Gene therapy for lung disease: hype or hope? Ann Int Med 2000; 132: 649–660.

    Article  CAS  Google Scholar 

  5. Loser P, Hillgenberg M, Arnold W, Both GW, Hofmann C . Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle. Gene Ther 2000; 7: 1491–1498.

    Article  CAS  Google Scholar 

  6. Yotdna P et al. Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses. Mol Ther 2002; 5: 233–241.

    Article  Google Scholar 

  7. Song JE et al. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther 2001; 8: 1299–1306.

    Article  CAS  Google Scholar 

  8. Stoll SM et al. Epstein-Barr virus/human vector provides high-level long-term expression of α1-antitrypsin in mice. Mol Ther 2001; 4: 122–129.

    Article  CAS  Google Scholar 

  9. Chen Z-Y et al. Linesa Dnas concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther 2001; 3: 403–410.

    Article  CAS  Google Scholar 

  10. Dasi F, Benet M, Crespo A, Alino SF . Asialofetuin liposome-mediated human α1- antitrypsin gene transfer in vivo results in stationary long-term gene expression. J Mol Med 2001; 79: 205–212.

    Article  CAS  Google Scholar 

  11. Metz R et al. Mode of action of RNA/DNA oligonucleotides: progress in the development of gene repair as a therapy for [alpha]1-antitrypsin deficiency. Chest 2002; 121: 91S–97S.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stecenko, A., Brigham, K. Gene Therapy Progress and Prospects: Alpha-1 antitrypsin. Gene Ther 10, 95–99 (2003). https://doi.org/10.1038/sj.gt.3301947

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301947

Keywords

This article is cited by

Search

Quick links